TREATMENT OF VERTIGO- WITH & WITHOUT ANXIOLYTIC DRUG (ALPRAZOLAM 0.25MG)

Muhammad Waqas Ayub; Syed Muhammad Asad Shabbir Bukhari; Mohsin Raza; Asma Waqas; Beenish Hassan Khan; Atif Najam

doi:10.51253/pafmj.v1i1.7922

Authors

Muhammad Waqas Ayub Combined Military Hospital Okara/National University of Medical Sciences (NUMS) Pakistan
Syed Muhammad Asad Shabbir Bukhari Pakistan Naval Ship Shifa, Karachi Pakistan
Mohsin Raza Combined Military Hospital Okara/National University of Medical Sciences (NUMS) Pakistan
Asma Waqas Fazal Din Trust Hospital, Okara Pakistan
Beenish Hassan Khan Combined Military Hospital Okara/National University of Medical Sciences (NUMS) Pakistan
Atif Najam Pakistan Naval Ship Hafeez, Islamabad Pakistan

DOI:

https://doi.org/10.51253/pafmj.v1i1.7922

Keywords:

Anxiety, Vertigo, Tablet alprazolam

Abstract

Objective: To compare the effect of using the tablet Alprazolam 0.25mg in the treatment outcome of vertigo related anxiety by beck anxiety inventory.

Study Design: Comparative study.

Place and Duration of Study: Combined Military Hospital Okara Cantt, Sep 2018 to Jun 2020.

Methodology: A total of 384 patients were included in the study. They were randomly assigned to group A and B by randomized clinical trial. Group A was given tablet alprazolam 0.25 mg along with the conventional treatment of vertigo and group B was given the treatment of vertigo only and no anxiolytic was added. Their pre & post treatment (after 2 weeks) anxiety level using Beck anxiety inventory was scored.

Results: There was a significant improvement in group A patient’s vertigo effects after treatment with alprazolam. Also, it was observed that group A patients responded significant improvement in anxiety score as compared to Group B patients 02 weeks post treatment.

Conclusion: Antianxiety treatment should be added in all cases with the conventional treatment of vertigo to reduce the vertigo associated anxiety of the patients.